Literature DB >> 16613553

Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter.

Tatyana D Sotnikova1, Jean-Martin Beaulieu, Raul R Gainetdinov, Marc G Caron.   

Abstract

The plasma membrane dopamine transporter (DAT) tightly regulates the extracellular concentrations of dopamine (DA) by re-capturing released neurotransmitter back into the presynaptic neuronal terminals and/or neighboring DA projections thereby providing an effective way to regulate synaptic and extrasynaptic DA levels. This transporter is a primary target of many potent psychotropic drugs and neurotoxins, such as cocaine, amphetamines and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this review we summarize recent advances in understanding the structure, regulation, and functional roles of DAT in normal DA physiology and pathological conditions, such as attention deficit hyperactivity disorder (ADHD) and neurodegenerative processes, as well as their contribution to the pharmacology of psychostimulant drugs. Significant new insights on these issues have been gained using mice with genetic deletion of DAT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613553     DOI: 10.2174/187152706784111579

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  25 in total

1.  Expression and distribution of dopamine transporter in cardiac tissues of the guinea pig.

Authors:  Alejandro Reynoso Palomar; Berenice Navarrete Larios; Victoria Chagoya De Sánchez; Lidia Martínez Pérez; Fidel De La Cruz López; Gonzalo Flores; Maria de Jesús Gómez-Villalobos
Journal:  Neurochem Res       Date:  2010-12-19       Impact factor: 3.996

Review 2.  Outside the box signaling: secreted factors modulate GnRH receptor-mediated gonadotropin regulation.

Authors:  Hanna Pincas; Soon Gang Choi; Qian Wang; Jingjing Jia; Judith L Turgeon; Stuart C Sealfon
Journal:  Mol Cell Endocrinol       Date:  2013-08-28       Impact factor: 4.102

Review 3.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

4.  Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.

Authors:  Pamela C Rodriguez; Daniela B Pereira; Anders Borgkvist; Minerva Y Wong; Candace Barnard; Mark S Sonders; Hui Zhang; Dalibor Sames; David Sulzer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

5.  Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.

Authors:  Padmanabhan Mannangatti; Santhanalakshmi Sundaramurthy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

6.  Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation.

Authors:  James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

7.  2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.

Authors:  Chamila C Kadigamuwa; Viet Q Le; Kandatege Wimalasena
Journal:  J Neurochem       Date:  2015-08-12       Impact factor: 5.372

Review 8.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

9.  Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Authors:  Valentina Ghisi; Amy J Ramsey; Bernard Masri; Raul R Gainetdinov; Marc G Caron; Ali Salahpour
Journal:  Cell Signal       Date:  2008-09-30       Impact factor: 4.315

10.  Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Authors:  Freja H Hansen; Tina Skjørringe; Saiqa Yasmeen; Natascha V Arends; Michelle A Sahai; Kevin Erreger; Thorvald F Andreassen; Marion Holy; Peter J Hamilton; Viruna Neergheen; Merete Karlsborg; Amy H Newman; Simon Pope; Simon J R Heales; Lars Friberg; Ian Law; Lars H Pinborg; Harald H Sitte; Claus Loland; Lei Shi; Harel Weinstein; Aurelio Galli; Lena E Hjermind; Lisbeth B Møller; Ulrik Gether
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.